Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
AIDS (London, England)|August 28, 2007
Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048-079 Trials)Christine Durier, Catherine Capitant, Anne-Sophie Lascaux, et al.
Vaccine|July 16, 2013
Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16)Odile Launay, Mathieu Surenaud, Corinne Desaint, et al.
AIDS (London, England)|June 14, 2013
Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteersLaura Richert, Sophie Hue, Hakim Hocini, et al.
AIDS (London, England)|August 11, 2018
Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patientsNathalie Colin de Verdiere, Christine Durier, Assia Samri, et al.
Vaccine|March 10, 2026
Ancestral Wuhan SARS-CoV-2 anti-spike CD4<sup>+</sup> T cells predict protection from symptomatic omicron breakthrough infectionChristine Durier, Nadine Benhamouda, Anissa Besbes, et al.
AIDS (London, England)|July 16, 2019
Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trialsChristine Durier, Corinne Desaint, Jean-Daniel Lelièvre, et al.
AIDS (London, England)|July 14, 2010
Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trialDominique Salmon-Céron, Christine Durier, Corinne Desaint, et al.
Plos One|July 15, 2017
Impact of early cART on HIV blood and semen compartments at the time of primary infectionAntoine Chéret, Christine Durier, Adeline Mélard, et al.
AIDS (London, England)|February 19, 2005
Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patientsYves Lévy, Hanne Gahéry-Ségard, Christine Durier, et al.
Plos One|June 1, 2017
Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotypeSéverine Mercier-Delarue, Christine Durier, Nathalie Colin de Verdière, et al.
Pageof 4